| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 06/03/2009 | EP2064214A1 Pyraz0l0(l,5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors |
| 06/03/2009 | EP2064180A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 06/03/2009 | EP2063962A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
| 06/03/2009 | EP2063896A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 06/03/2009 | EP1696912A4 Pyrazolopyridines and analogs thereof |
| 06/03/2009 | EP1613319B1 Substituted phenyl acetamides and their use as protease inhibitors |
| 06/03/2009 | EP1608656B1 Imidazotriazine compounds for the treatment of cancer diseases |
| 06/03/2009 | EP1330458B1 N-( 1,2,4 triazoloazinyl) thiophenesulfonamide compounds as herbicides |
| 06/03/2009 | EP1313737B1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 06/03/2009 | CN101448836A Pyridopyrimidinone derivatives |
| 06/03/2009 | CN101448835A 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of trpvl for the treatment of pain |
| 06/03/2009 | CN101448834A 2-arylpyrazolo[l,5-a]pyrimidin-3-yl acetamide derivatives as ligands for translocator protein (18 kda) |
| 06/03/2009 | CN101448833A Crystalline forms of 5-chloro-6- (2, 6-difluoro-4- [3- (methylamino) propoxy] phenyl)-n-((1s)-2, 2, 2,-trifluoro-1-methylethyl] [1,2,4] triazolo [1,5-a] pyrimidin-7-amine salts |
| 06/03/2009 | CN101448832A Aldosterone synthase and/or 11beta-hydroxylase inhibitors |
| 06/03/2009 | CN101448831A Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands |
| 06/03/2009 | CN100494201C Metal aza porphyrin compound containing fluorene diaryl ethylene and its preparation method and application |
| 06/03/2009 | CN100494177C Bi-amido heterocyclic derivative with antitumour activity and its preparation method and use |
| 06/02/2009 | US7541457 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541373 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541354 Bicyclo-pyrazoles |
| 06/02/2009 | US7541096 Blue emitting, durable, organoelectrouminescent layers containing 2H-benzotriazole compounds; full color display panels; light emission efficiency and brightness |
| 06/02/2009 | CA2433833C Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 06/02/2009 | CA2425395C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 05/28/2009 | WO2009067586A1 Biaryl substituted diazabicycloalkane derivatives |
| 05/28/2009 | WO2009067547A1 Polo-like kinase inhibitors |
| 05/28/2009 | WO2009067541A2 Integrase inhibitors |
| 05/28/2009 | WO2009067481A1 Compounds for the treatment of hepatitis c |
| 05/28/2009 | WO2009067275A1 N-oxides of 4,5-epoxy-morphinanium analogs |
| 05/28/2009 | WO2009067108A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 05/28/2009 | WO2009066892A1 Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein |
| 05/28/2009 | WO2009065472A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 05/28/2009 | WO2009065298A1 Piperazine derivatives, preparation process and pharmaceutical use thereof |
| 05/28/2009 | WO2009029384A3 Compounds for the treatment of hepatitis c |
| 05/28/2009 | US20090137806 Dual nk1/nk3 receptor antagonists |
| 05/28/2009 | US20090137795 New route to formyl-porphyrins |
| 05/28/2009 | US20090137650 New Compounds |
| 05/28/2009 | US20090137623 Muscarinic receptor antagonists |
| 05/28/2009 | US20090137607 6-phenyl-7-(4-{[4-(3-pyridin-2-yl-1,2,4-triazol-5-yl)piperidin-1-yl]methyl}phenyl)imidazo[1,2a]-pyrimidine; phosphatidyl inositol 3-kinase inhibitors; anticancer agents; apoptosis |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137597 Novel quinoxalinone derivatives |
| 05/28/2009 | US20090137596 G-protein inhibitor |
| 05/28/2009 | US20090137595 Fused heterocyclic derivative and use thereof |
| 05/28/2009 | US20090137594 Pentafluorosulphanyl-Substituted Compound And Its Use For Producing Medicaments |
| 05/28/2009 | US20090137581 Heterocyclic compounds and their uses |
| 05/28/2009 | US20090137580 Fused Heterocyclic Derivatives and Use Thereof |
| 05/28/2009 | US20090137557 Calcilytic Compounds |
| 05/28/2009 | US20090137555 activity of CDK1, CDK2, CDK4, CDK5, GSK3 beta , Bcr-ab1, Flt-3, c-Kit, PDGFR beta , Src, Mek1 and CK1; 2-[N'-(2,3-dibromo-8-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-c]azepin-4-ylidene)-hydrazino]-benzoic acid; antiinflammatory agent; autoimmune, neurological, cardiovasculal, hormone-related diseases |
| 05/28/2009 | US20090137554 1,4,5,6-TETRAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY |
| 05/28/2009 | US20090137550 Novel Compounds |
| 05/28/2009 | US20090137549 Novel compounds useful for the treatment of degenerative & inflamatory diseases |
| 05/28/2009 | US20090137547 Heterobicyclic metalloprotease inhibitors |
| 05/28/2009 | US20090136979 Class IIA Histone Deacetylase (HDAC) Substrate |
| 05/28/2009 | US20090136974 Luciferin Luminescent Substrate of Marine Ostracod Crustacean and Method for Production Thereof |
| 05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
| 05/28/2009 | US20090136513 Bicyclo-pyrazoles active as kinase inhibitors |
| 05/28/2009 | US20090136449 Tetracyclic Indole Derivatives as Antiviral Agents |
| 05/28/2009 | US20090136448 Antiviral 2-Carboxy-Thiophene Compounds |
| 05/28/2009 | CA2705011A1 Biaryl substituted diazabicycloalkane derivatives |
| 05/28/2009 | CA2703887A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 05/27/2009 | EP2062895A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 05/27/2009 | EP2062893A1 Fused imidazoles for cancer treatment |
| 05/27/2009 | EP2062050A2 Modulation of chemosensory receptors and ligands associated therewith |
| 05/27/2009 | EP2061796A2 Azetidine and azetidinone derivatives useful in treating pain and disorders of lipid metabolism |
| 05/27/2009 | EP2061795A2 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 05/27/2009 | EP2061771A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 05/27/2009 | EP2061770A1 Piperazine compounds with herbicidal action |
| 05/27/2009 | EP2061470A2 Haloalkyl-substituted pyrimidinone derivatives |
| 05/27/2009 | EP2061322A2 Pharmacokinetically improved compounds |
| 05/27/2009 | EP1968581A4 Tetracyclic kinase inhibitors |
| 05/27/2009 | EP1960403B1 Pyrrolotriazine kinase inhibitors |
| 05/27/2009 | EP1679747B1 Organic thin film transistor |
| 05/27/2009 | EP1622912B1 2-alkynyl-and 2-alkenyl-pyrazolo- [4,3-e ] -1,2,4-triazolo- [1,5-c] -pyrimidine adenosine a2a receptor antagonists |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1487797B1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors |
| 05/27/2009 | EP1250140B1 Combination ofan abl-, pdgf-receptor- and/or kit receptor-tyrosine kinase inhibitor with an organic compound capable of binding to alpha1-acidic glycoprotein |
| 05/27/2009 | CN101443331A Triazolopyrazine derivatives useful as anti-cancer agents |
| 05/27/2009 | CN101443013A Pyrazolo [3,4-d] pyrimidine derivatives useful to treat respiratory disorders |
| 05/27/2009 | CN101440089A Compositions, methods and kits pertaining to luminescent compounds |
| 05/27/2009 | CN101440073A Aromatic chlorethazine piperazine quaternary ammonium salt derivatives, and preparation and use thereof |
| 05/27/2009 | CN101440066A Benzodiazepinic amine nitrite compound, preparation and use thereof |
| 05/27/2009 | CN100491378C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 05/27/2009 | CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/26/2009 | US7538341 Electronic device comprising organic compound having p-type semiconducting characteristics |
| 05/26/2009 | US7538226 (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 05/26/2009 | US7538112 hydroxy-substituted pyrazinopyrrolopyridazine dione compounds; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(2-fluorobenzyl)-10-hydroxy-4,8-dimethyl-7,8-dihydropyrazino[1',2':1,5]-pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-dione |
| 05/26/2009 | US7538104 Photoactivable nitrogen bases |
| 05/26/2009 | US7537912 Such as acetoxymethyl diacetyl-coelenterazine, which is contacted with luciferase; protected luminophore provides increased stability and improved signal-to-background ratios relative to the corresponding unmodified coelenterazine |
| 05/26/2009 | CA2533685C Nitrogen-containing fused heterocyclic carboxylic acid compounds |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2445478C Retinol derivatives potentiation of active substances by micellar preparation |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/22/2009 | WO2009064848A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 05/22/2009 | WO2009064802A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 05/22/2009 | WO2009064476A1 Preparation of sitagliptin intermediate |
| 05/22/2009 | WO2009064418A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 05/22/2009 | WO2009063990A1 Benzazepinone compound |
| 05/22/2009 | WO2009063504A2 Novel crystal modification of epinastine or salts thereof and process for preparation thereof |
| 05/22/2009 | WO2009063486A2 Process for preparation of dextrorotatory isomer of 6-(5-chloro-pyrid-2-yi)-5-[(4-methyl -1-piperazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo [3,4-b] pyrazine (eszopiclone) |